Cacao Flavanols Cognitive Performance Randomized Trial: What the Evidence Says
Cacao Flavanols Cognitive Performance Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this
Quick Answer
Cacao Flavanols Cognitive Performance Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public health sources, so conclusions should be framed as evidence aware guidance rather than medical advice.
Key Takeaways
- 01This page is generated only from sources stored in the Migaku evidence knowledge base.
- 02Current evidence mix: 1 research article.
- 03Claims should be interpreted with the source type, study design, population, and publication date in mind.
- 04This article is educational and does not replace care from a qualified clinician.
Cacao Flavanols Cognitive Performance Randomized Trial: What the Evidence Says
Quick Answer
Cacao Flavanols Cognitive Performance Randomized Trial has 1 source documents in the current Migaku evidence database. The strongest available sources in this first pass are mixed biomedical and public-health sources, so conclusions should be framed as evidence-aware guidance rather than medical advice.
Key Takeaways
- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.
Evidence Map
| Source | Evidence type | Level | Date | Identifier |
|---|---|---|---|---|
| Comparable improvements in selective, but not sustained, attention in response to a multi-ingredient nootropic formulation when compared with caffeine | research article | 4 | 2026-03-02 | 10.1007/s00394-026-03926-8 |
What The Sources Report
- As such, caffeine can enhance concentrations of important neurotransmitters such as dopamine, the result of which prevents alertness and attention decrements associated with low arousal. [Hearris Mark A. (2026); evidence level 4]
- The effects of caffeine on cognitive performance are, however, largely restricted to improved alertness and enhanced concentration or attention and do not typically extend to other cognitive domains such as working memory and executive function. [Hearris Mark A. (2026); evidence level 4]
How To Read This Evidence
Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.
Practical Interpretation
For cacao flavanols cognitive performance randomized trial, the current source set is useful for orientation, but it is not yet broad enough for strong claims. Use cautious language and keep conclusions close to the cited sources.
Limits Of This First Pass
This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.
References
- Hearris Mark A. (2026). Comparable improvements in selective, but not sustained, attention in response to a multi-ingredient nootropic formulation when compared with caffeine. DOI: 10.1007/s00394-026-03926-8. PMCID: PMC12953322. PMID: 41770378. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12953322/
Safety Note
Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.
FAQ
Frequently Asked Questions
Medically reviewed
Last reviewed July 24, 2026 by Migaku Evidence Review
